Alea Research
Phoenix, Arizona, United States
Research institute in Phoenix, Arizona
3030 N Central Ave, Phoenix, AZ 85012
About Alea Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
3
Biohaven Pharmaceuticals, Inc.
2
Naurex, Inc, an affiliate of Allergan plc
2
Allergan
1
Boehringer Ingelheim
1
Denovo Biopharma LLC
1
Gate Neurosciences, Inc
1
Otsuka Pharmaceutical Development & Commercialization, Inc.
1
Satsuma Pharmaceuticals, Inc.
1
Sirtsei Pharmaceuticals, Inc.
1
Clinical Trials at Alea Research
During the past decade, Alea Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on
average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months
2017-12-07
2021-03-31
Terminated
264
Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)
2018-08-02
2019-07-11
Terminated
363
A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
2019-04-29
2020-09-29
Terminated
277
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
2019-06-24
2020-08-13
Completed
1,201
Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine
2019-05-06
2021-03-31
Completed
685
A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
2020-09-30
2022-06-27
Completed
319
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Alea Research" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Biohaven Pharmaceuticals, Inc." with 2 trials
sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Boehringer Ingelheim"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
Clinical Trials Conditions at Alea Research
According to Clinical.Site data, the most researched conditions in "Alea Research" are
"Depressive Disorder, Major" (5 trials), "Major Depressive Disorder" (2 trials), "Schizophrenia" (2 trials), "Anhedonia" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "Alea Research" in a lesser frequency.
Clinical Trials Intervention Types at Alea Research
Most popular intervention types in "Alea Research" are "Drug" (13 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Aticaprant" (2 trials), "Rapastinel" (2 trials), "AGN-241751" (1 trials) and "Abilify MyCite®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Alea Research
The vast majority of trials in "Alea Research" are
14 trials for "All" genders.
Clinical Trials Status at Alea Research
Currently, there are NaN active trials in "Alea Research".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 4 completed trials in Alea Research,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Alea Research, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".